These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. Agrawal NM, Dajani EZ. J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964 [Abstract] [Full Text] [Related]
7. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs. Agrawal NM, Dajani EZ. J Assoc Acad Minor Phys; 1992 Feb; 3(4):142-8. PubMed ID: 1392409 [Abstract] [Full Text] [Related]
8. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY. Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000 [Abstract] [Full Text] [Related]
9. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Lazzaroni M, Bianchi Porro G. Dig Liver Dis; 2001 Dec 08; 33 Suppl 2():S44-58. PubMed ID: 11827362 [Abstract] [Full Text] [Related]
10. Prevention of NSAID-induced GI mucosal injury. Gerritz S, Newton WP. J Fam Pract; 1997 Feb 08; 44(2):130-1. PubMed ID: 9040509 [No Abstract] [Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep 08; 20(119):216-9. PubMed ID: 21954519 [Abstract] [Full Text] [Related]
12. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. Naesdal J, Wilson I. Eur J Gastroenterol Hepatol; 2001 Dec 08; 13(12):1401-6. PubMed ID: 11742186 [Abstract] [Full Text] [Related]
13. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM. J Clin Gastroenterol; 1990 Dec 08; 12 Suppl 2():S13-20. PubMed ID: 1978842 [Abstract] [Full Text] [Related]
14. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers. Scheiman J, Isenberg J. Am J Med; 1998 Nov 02; 105(5A):32S-38S. PubMed ID: 9855174 [Abstract] [Full Text] [Related]
15. NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis. Stalnikowicz R, Rachmilewitz D. J Clin Gastroenterol; 1993 Oct 02; 17(3):238-43. PubMed ID: 7901267 [Abstract] [Full Text] [Related]
16. Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy. Lee M. South Med J; 1995 May 02; 88(5):507-13. PubMed ID: 7732438 [Abstract] [Full Text] [Related]
17. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management. Scheiman JM. Dig Dis; 1994 May 02; 12(4):210-22. PubMed ID: 7851000 [Abstract] [Full Text] [Related]
18. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F. Drug Saf; 1999 Jun 02; 20(6):527-43. PubMed ID: 10392669 [Abstract] [Full Text] [Related]
19. Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications. Hayllar J, Macpherson A, Bjarnason I. Drug Saf; 1992 Jun 02; 7(2):86-105. PubMed ID: 1605904 [Abstract] [Full Text] [Related]
20. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Scarpignato C, Pelosini I. Ital J Gastroenterol Hepatol; 1999 Jun 02; 31 Suppl 1():S63-72. PubMed ID: 10379472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]